Healthcare DIVE June 16, 2021
Rebecca Pifer

Two influential advisory groups sent recommendations to Congress calling for a revamp of how health plans are paid in the lucrative Medicare Advantage program, culling how many models CMS tests and curbing high-cost drug approvals.

By many measures, the MA program has been thriving. Enrollment and participation has continued to grow, and in 2021, MA plans’ bids to provide the Medicare benefit declined to a record low: Just 87% of comparable fee-for-service spending in their markets.

But despite that relative efficiency, MA contracting isn’t saving Medicare money — actually, in the 35 years Medicare managed care has been active, it’s never resulted in net savings for the cash-strapped program, James Mathews, executive director of the Medicare Payment Advisory Commission, told...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Congress / White House, Govt Agencies, Insurance, Medicare Advantage, Payer, Payment Models, Provider, Value Based
2026 Medicare Advantage rates 'inadequate,' Elevance execs say
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
‘A Bit Disarming’: CMS, Health Agencies Pause Communication Per Trump Orders, Raising Concerns at Nursing Homes
CMS Moves Closer to Accountable Care Goals with 2025 ACO Initiatives

Share This Article